| 19461491 |
Untitled |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
MIDDLETON, DANAYA L |
|
§103§112 |
Non-Final OA |
— |
Pending |
|
| 19637493 |
JELLYFISH COLLAGEN USE |
Jellagen Limited |
MELLER, MICHAEL V |
1655 |
§103 |
Non-Final OA |
— |
Pending |
Apr 02, 2026 |
| 19363455 |
METHOD FOR PRODUCING AND PURIFYING RNA, COMPRISING AT LEAST ONE STEP OF TANGENTIAL FLOW FILTRATION |
Curevac Manufacturing GmbH |
BAKSHI, PANCHAM |
1623 |
§103 |
Non-Final OA |
— |
Pending |
Oct 20, 2025 |
| 19118598 |
MODIFYING EARLY-STAGE PARKINSON'S DISEASE PROGRESSION WITH DEEP BRAIN STIMULATION |
VANDERBILT UNIVERSITY |
ROY, BAISAKHI |
3797 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Apr 04, 2025 |
| 19083757 |
DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF |
Rein Therapeutics, Inc. |
GEMBEH, SHIRLEY V |
1615 |
DP |
Non-Final OA |
— |
Pending |
Mar 19, 2025 |
| 19110271 |
COMPOSITION FOR ENHANCING IMMUNITY |
Kolmar Bnh Co., Ltd. |
SPAINE, ROBERT FRANKLIN |
1655 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Mar 10, 2025 |
| 19052850 |
ELECTRIC-FIELD DIRECTED NERVE REGENERATION |
UNIVERSITY OF SOUTHERN CALIFORNIA |
LEE, BRYAN MCALLISTER |
3796 |
§101§103 |
Non-Final OA |
— |
Pending |
Feb 13, 2025 |
| 19042229 |
DEVICES, SYSTEMS AND METHODS FOR CLEANING OF ELONGATED INSTRUMENT SURFACE |
Ascension Texas |
HENDERSON, RYAN N |
3795 |
§102§112Other |
Non-Final OA |
— |
Pending |
Jan 31, 2025 |
| 19002848 |
METHODS FOR OPTIMIZING THE PLANNING AND PLACEMENT OF PROBES IN THE BRAIN VIA MULTIMODAL 3D ANALYSES OF CEREBRAL ANATOMY |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
WILBURN, MOLLY K |
|
Other |
Non-Final OA |
— |
Pending |
Dec 27, 2024 |
| 18980005 |
SYSTEMS AND METHODS FOR CORONARY OCCLUSION TREATMENT |
Research Development Foundation |
LAU, MICHAEL J |
3796 |
§103§112 |
Non-Final OA |
— |
Pending |
Dec 13, 2024 |
| 18873924 |
ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS |
The Board Of Regents Of The University Of Oklahoma |
MCCULLOUGH, ERIC J. |
1773 |
§103§112 |
Final Rejection |
42d overdue |
Pending |
Dec 11, 2024 |
| 18872223 |
APOMORPHINE PRODRUGS AND USES THEREOF |
Ever Neuro Pharma GmbH |
BRAUN, MADELINE E |
1629 |
§103§112 |
Non-Final OA |
— |
Pending |
Dec 05, 2024 |
| 18858186 |
REAL-TIME BREATH ADAPTIVE NEBULIZER APPARATUS AND METHODS FOR PULMONARY THERAPEUTIC AGENT DELIVERY |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
ALBERS, KEVIN S |
3786 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 18, 2024 |
| 18857661 |
MAGNETICALLY STEERABLE CATHETER |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
KOLKIN, ADAM D. |
3798 |
§103 |
Non-Final OA |
7d |
Pending |
Oct 17, 2024 |
| 18856686 |
DELIVERY SYSTEM TO TARGET GRAM-NEGATIVE BACTERIA |
The Wistar Institute |
SHIAO, REI TSANG |
1691 |
§112 |
Non-Final OA |
— |
Pending |
Oct 14, 2024 |
| 18856725 |
DLC COATING AND PREPARATION METHOD AND DEVICE THEREFOR, COMPOSITE COATING LAYER AND COATED PRODUCT |
Jiangsu Favored Nanotechnology Co., Ltd. |
HORGER, KIM S. |
1717 |
§103 |
Non-Final OA |
— |
Pending |
Oct 14, 2024 |
| 18886115 |
MACS-BASED PURIFICATION OF STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM |
Fujifilm Cellular Dynamics, Inc. |
BERTOGLIO, VALARIE E |
|
§101§102§112Other |
Non-Final OA |
— |
Pending |
Sep 16, 2024 |
| 18846000 |
IRREVERSIBLE ORGANIC ELECTROCHROMIC MATERIALS |
UNIVERSITAET WIEN |
JONES, JENNIFER ANN |
2872 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Sep 11, 2024 |
| 18789888 |
BIOCHEMICAL AND BIOMECHANICAL CONDITIONING FOR ENHANCING PERSONALIZED MESENCHYMAL STEM CELL THERAPIES |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
KNIGHT, TERESA E |
1634 |
DP |
Non-Final OA |
— |
Pending |
Jul 31, 2024 |
| 18833889 |
NUCLEIC ACID ENCODED TRANSCRIPTION FACTOR INHIBITORS |
The Schepens Eye Research Institute, Inc. |
DAVIS, BRIAN J |
1614 |
§112 |
Final Rejection |
— |
Pending |
Jul 27, 2024 |
| 18728949 |
ISOCITRATE DEHYDROGENASE 1 INHIBITORS AND METHODS OF USE THEREOF |
Case Western Reserve University |
ROMERO, KRISTEN WANG |
1624 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Jul 15, 2024 |
| 18763115 |
APPARATUS AND METHODS FOR COMPUTATIONALLY INFORMED ADHESION MEASUREMENT USING THE BLISTER TEST |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
DEVITO, ALEX T |
2855 |
§102§103 |
Non-Final OA |
— |
Pending |
Jul 03, 2024 |
| 18723672 |
NOVEL LEUKOTRIENE B4 RECEPTOR INHIBITORS AND USE THEREOF |
Dongguk University Industry-Academic Cooperation Foundation |
MCKOY, QUINCY ANDRE |
1626 |
§102DP |
Non-Final OA |
— |
Pending |
Jun 24, 2024 |
| 18723083 |
MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON |
Suzhou Kintor Pharmaceuticals, Inc. |
TOWNSLEY, SARA ELIZABETH |
1629 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Jun 21, 2024 |
| 18742139 |
DRUG SCREENING METHOD AND MODEL FOR MONITORING PLATINUM-RESISTANT OVARIAN CANCER TUMOR GROWTH AND METASTASES |
The Board Of Regents Of The University Of Oklahoma |
RAGHU, GANAPATHIRAM |
1652 |
§102§103§112 |
Final Rejection |
— |
Pending |
Jun 13, 2024 |
| 18718892 |
VACCINE PREPARATION |
Hcemm Nonprofit Kft. |
GRIZER, CASSANDRA SENN |
1672 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Jun 12, 2024 |
| 18710555 |
ULTRA PH-SENSITIVE MICELLES ENCAPSULATING CYTOKINES FOR TREATMENT OF CANCER |
The Board Of Regents Of The University Of Texas System |
CRAIGO, WILLIAM A |
1615 |
§103§112 |
Non-Final OA |
— |
Pending |
May 15, 2024 |
| 18706890 |
MONOVALENT ANION SELECTIVE MEMBRANE ENABLED BY HIGH CONCENTRATION BRINE |
Energy Exploration Technologies, Inc. |
SPIES, BRADLEY R |
|
§103 |
Non-Final OA |
— |
Pending |
May 02, 2024 |
| 18649976 |
METHODS OF USE OF MODULATORS TO IMPROVE NERVE REGENERATION |
Edward Keefer |
CHERNYSHEV, OLGA N |
1675 |
§112DP |
Non-Final OA |
— |
Pending |
Apr 29, 2024 |
| 18705047 |
INTRA-OPERATIVELY FITTED ANTIBIOTIC SPACER SYSTEM |
The Board Of Regents Of The University Of Texas System |
FLORES, ADRIAN |
3774 |
§102§103 |
Non-Final OA |
— |
Pending |
Apr 26, 2024 |
| 18705061 |
DRY POWDER COMPOSITIONS COMPRISING EUKARYOTIC CELLS AND METHOD OF THEIR MANUFACTURE AND USE |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
GEMBEH, SHIRLEY V |
1615 |
§102§103 |
Final Rejection |
70d |
Pending |
Apr 26, 2024 |
| 18705499 |
IMPROVED CIRCULAR RNA FOR EXPRESSING THERAPEUTIC PROTEINS |
CUREVAC SE |
MIANO, JOSEPH PAUL |
1631 |
§102§103 |
Non-Final OA |
— |
Pending |
Apr 26, 2024 |
| 18703615 |
NOVEL CRISPR/CAS13 SYSTEMS AND USES THEREOF |
Casbio (S) Pte. Ltd. |
LANDSMAN, ROBERT S |
1647 |
§112 |
Non-Final OA |
— |
Pending |
Apr 22, 2024 |
| 18701465 |
FACILE DIRECT AMINATION AND ALKYLAMINATION OF CARBON NANOTUBES |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
RHOADES, DEREK JAMES |
1692 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Apr 15, 2024 |
| 18700877 |
SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS |
Centre National De La Recherche Scientifique (Cnrs) |
LADD, CAROLYN LOUISE |
1622 |
§103 |
Non-Final OA |
— |
Pending |
Apr 12, 2024 |
| 18634454 |
FORMATION OF STABLE SUBMICRON PEPTIDE OR PROTEIN PARTICLES BY THIN FILM FREEZING |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
BECKHARDT, LYNDSEY MARIE |
1613 |
§103§112DP |
Non-Final OA |
— |
Pending |
Apr 12, 2024 |
| 18632697 |
BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME |
Musc Foundation For Research Development |
COUNTS, GARY W |
1678 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Apr 11, 2024 |
| 18698615 |
COMPOSITE COATING, PREPARATION METHOD, AND DEVICE |
Jiangsu Favored Nanotechnology Co., Ltd. |
MILLER, BETHANY MACKENZIE |
1787 |
§103 |
Final Rejection |
27d |
Pending |
Apr 04, 2024 |
| 18627146 |
HYBRID GOLD NANOPARTICLE-LIPID NANOPARTICLES AND METHODS OF USE AND PRODUCTION THEREOF |
The Board Of Regents Of The University Of Oklahoma |
SONG, JIANFENG |
1613 |
§103 |
Non-Final OA |
— |
Pending |
Apr 04, 2024 |
| 18619514 |
COMBINATION THERAPIES FOR THE TREATMENT OF DISEASES |
Research Development Foundation |
ARIANI, KADE |
1651 |
§103§112DP |
Non-Final OA |
— |
Pending |
Mar 28, 2024 |
| 18688749 |
NOVEL LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS |
CUREVAC SE |
HOERNER, PAUL ELLSWORTH |
1611 |
§102§103 |
Non-Final OA |
— |
Pending |
Mar 01, 2024 |
| 18585375 |
TRANSCRIPTION TERMINATOR BIOPARTS BASED ON 3'-UNTRANSLATED REGION (UTR) AND A METABOLIC ENGINEERING METHOD THEREOF |
Korea Advanced Institute Of Science And Technology |
REGLAS, GEORGIANA C |
1656 |
§101§102§103 |
Non-Final OA |
— |
Pending |
Feb 23, 2024 |
| 18582620 |
METHODS AND MEANS FOR ENHANCING RNA PRODUCTION |
Curevac Manufacturing GmbH |
DACE DENITO, ALEXANDRA GERALDINE |
1636 |
§103§112DP |
Non-Final OA |
— |
Pending |
Feb 20, 2024 |
| 18436313 |
SYSTEMS AND METHODS FOR STRESS DETECTION USING KINEMATIC DATA |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
PHUNG, STEVEN HUYNH |
2125 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
Feb 08, 2024 |
| 18432898 |
METHOD FOR ANALYZING BY-PRODUCTS OF RNA IN VITRO TRANSCRIPTION |
Curevac Manufacturing GmbH |
ADAMS, MICHELLE |
1797 |
§103§112 |
Final Rejection |
42d overdue |
Pending |
Feb 05, 2024 |
| 18292366 |
IMPROVED DRUG PROCESSING METHODS TO INCREASE DRUG LOADING |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
SAEED, ALI S |
1616 |
§103DP |
Non-Final OA |
10d overdue |
Pending |
Jan 26, 2024 |
| 18291318 |
MYOGENIC PROGENITOR CELLS FOR USE IN AN OPTIMIZED METHOD FOR THE PREVENTION AND TREATMENT OF ANAL INCONTINENCE |
Innovacell GmbH |
NGUYEN, NGHI V |
1653 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Jan 23, 2024 |
| 18419370 |
COMPOSITIONS, METHODS AND USES FOR TREATING CYSTIC FIBROSIS AND RELATED DISORDERS |
The Board Of Regents Of The University Of Texas System |
VANHORN, ABIGAIL LOUISE |
1636 |
§103§112Other |
Non-Final OA |
— |
Pending |
Jan 22, 2024 |
| 18415477 |
ARTIFICIAL NUCLEIC ACID MOLECULES |
CUREVAC SE |
BERTOGLIO, VALARIE E |
1632 |
§103§112 |
Non-Final OA |
11d overdue |
Pending |
Jan 17, 2024 |
| 18413541 |
METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS |
Research Development Foundation |
PAGUIO FRISING, MICHELLE F |
1651 |
§103DP |
Non-Final OA |
84d |
Pending |
Jan 16, 2024 |
| 18577066 |
MOLECULAR SORBENT COMPOSITIONS AND METHODS OF USE THEREOF |
The Board Of Regents Of The University Of Texas System |
BONAPARTE, AMY C |
1692 |
§112 |
Non-Final OA |
— |
Pending |
Jan 05, 2024 |
| 18545837 |
EXTRACELLULAR VESICLE-ENRICHED SECRETOME COMPOSITION DERIVED FROM INDUCED PLURIPOTENT STEM CELL DERIVED-MICROGLIA AND METHODS OF USE THEREOF |
Fujifilm Holdings America Corporation |
BOECKELMAN, JACOB A |
1655 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Dec 19, 2023 |
| 18570949 |
METHODS FOR IN VIVO DELIVERY OF MICROBES TO HUMAN MICROENVIRONMENTS |
BAYLOR COLLEGE OF MEDICINE |
BAEK, JONGHWAN NMN |
1618 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Dec 15, 2023 |
| 18565765 |
NOVEL PRODUCTION METHOD OF FLAVOCYTOCHROME B2 |
Directsens GmbH |
PAK, YONG D |
1652 |
§103§112 |
Non-Final OA |
— |
Pending |
Nov 30, 2023 |
| 18563790 |
CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR |
The Board Of Regents Of The University Of Texas System |
ALLEN, SARAH ELIZABETH |
|
§102§103§112 |
Non-Final OA |
— |
Pending |
Nov 22, 2023 |
| 18561889 |
CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY |
UNIVERSITY OF SOUTHERN CALIFORNIA |
WESTON, ALYSSA G |
1633 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Nov 17, 2023 |
| 18561413 |
MULTI-SPECIFIC ANTIBODY CONSTRUCTS AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ED) |
DANA-FARBER CANCER INSTITUTE, INC. |
CHASE, CAROL ANN |
1646 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Nov 16, 2023 |
| 18508192 |
LIPOCATIONIC DENDRIMERS AND USES THEREOF |
The Board Of Regents Of The University Of Texas System |
VANHORN, ABIGAIL LOUISE |
1616 |
Other |
Non-Final OA |
— |
Pending |
Nov 13, 2023 |
| 18559460 |
METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF ADENO-ASSOCIATED VIRAL VECTOR AND OTHER MOLECULES |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
KNIGHT, TERESA E |
1634 |
§103 |
Non-Final OA |
— |
Pending |
Nov 07, 2023 |
| 18558531 |
IMPROVED NUCLEIC ACID SEQUENCE FOR CELL TYPE SPECIFIC EXPRESSION |
CUREVAC SE |
RAHMAN, MASUDUR |
1633 |
§101§102§103 |
Non-Final OA |
— |
Pending |
Nov 01, 2023 |
| 18499054 |
GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET |
The Government Of The United States Of America AS Represented By The Secretary |
TAYLOR, LIA ELAN |
1641 |
§112Other |
Final Rejection |
— |
Pending |
Oct 31, 2023 |
| 18557747 |
COMPOSITIONS AND METHODS FOR CHIMERIC AMPLICON FORMATION |
William Marsh Rice University |
SALMON, KATHERINE D |
1682 |
§101§102 |
Final Rejection |
28d overdue |
Pending |
Oct 27, 2023 |
| 18496026 |
ENGINEERED LIPOSOMES FOR NEUTRALIZATION OF SARS-COV-2 AND OTHER ENVELOPED VIRUSES |
VANDERBILT UNIVERSITY |
WANG, RUIXUE |
1672 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 27, 2023 |
| 18557371 |
A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO |
Helsingin Yliopisto |
ANDERSON, REBECCA L |
1626 |
§103§112Other |
Non-Final OA |
— |
Pending |
Oct 26, 2023 |
| 18557033 |
ADENO-ASSOCIATED VIRAL VECTORS FOR TRANSDUCTION OF COCHLEA |
The Children's Hospital of Philadelphia |
MATALKAH, FATIMAH KHALAF |
1638 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 24, 2023 |
| 18556648 |
ANTIBODY COCKTAIL FOR TREATMENT OF EBOLAVIRUS INFECTIONS |
VANDERBILT UNIVERSITY |
LU, CHENG |
1642 |
§102§103§112 |
Final Rejection |
— |
Pending |
Oct 20, 2023 |
| 18490131 |
ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT |
The Board Of Regents Of The University Of Texas System |
CHONG, KIMBERLY |
1636 |
§103§112DP |
Non-Final OA |
— |
Pending |
Oct 19, 2023 |
| 18554103 |
DOPAMINERGIC PRECURSOR CELLS AND METHODS OF USE |
Fujifilm Cellular Dynamics, Inc. |
NGUYEN, NGHI V |
1653 |
§102§112DP |
Non-Final OA |
— |
Pending |
Oct 05, 2023 |
| 18553893 |
ANTIMICROBIAL ELUTING AIRWAY DEVICES |
The Children's Hospital of Philadelphia |
CRAIGO, WILLIAM A |
1615 |
§103 |
Final Rejection |
— |
Pending |
Oct 04, 2023 |
| 18553840 |
DONOR-ACCEPTOR CONJUGATED OLIGOELECTROLYTES FOR CELL LABELLING AND METHODS THEREOF |
National University Of Singapore |
CHONG, YONG SOO |
1623 |
§102Other |
Non-Final OA |
— |
Pending |
Oct 03, 2023 |
| 18479052 |
APPARATUS AND METHODS FOR DELIVERY OF CELL COMPOSITIONS |
Fujifilm Cellular Dynamics, Inc. |
SUNG, GERALD LUTHER |
3741 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Sep 30, 2023 |
| 18285227 |
COMPOSITIONS AND METHODS FOR MODULTING INFLAMMATORY AND DEGENERATIVE DISORDER |
UNIVERSITY OF SOUTHERN CALIFORNIA |
LEE, JIA-HAI |
1658 |
§101§102§103DP |
Non-Final OA |
— |
Pending |
Sep 29, 2023 |
| 18553531 |
SYRINGES CONTAINING PHARMACEUTICAL COMPOSITIONS COMPRISING RNA |
CUREVAC SE |
RYAN, DOUGLAS CHARLES |
1635 |
§103 |
Final Rejection |
12d |
Pending |
Sep 29, 2023 |
| 18552262 |
NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING |
The Board Of Regents Of The University Of Texas System |
CORDAS, EMILY ANN |
1632 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 25, 2023 |
| 18471280 |
COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA |
The Board Of Regents Of The University Of Texas System |
CHONG, KIMBERLY |
1636 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 20, 2023 |
| 18465333 |
COMPOSITONS AND METHODS FOR USE OF KALIUM CHANNEL RHODOPSINS |
BAYLOR COLLEGE OF MEDICINE |
POPA, ILEANA |
1633 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Sep 12, 2023 |
| 18549844 |
GENERATION OF HUMAN PEANUT ALLERGEN-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE |
VANDERBILT UNIVERSITY |
SANG, HONG |
1646 |
§112 |
Non-Final OA |
— |
Pending |
Sep 08, 2023 |
| 18549645 |
DRY POWDER FORMULATIONS OF NUCLEIC ACID LIPID NANOPARTICLES |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
SHOMER, ISAAC |
1612 |
§102§103 |
Non-Final OA |
— |
Pending |
Sep 08, 2023 |
| 18463282 |
USE OF SDHA AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN UVEAL MELANOMA |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
SALMON, KATHERINE D |
1682 |
§103 |
Final Rejection |
161d overdue |
Pending |
Sep 07, 2023 |
| 18548413 |
COLLAGENOUS EXTRACTS FOR USE AS A MEDICAMENT |
Jellagen Ltd. |
KATAKAM, SUDHAKAR |
1658 |
§102§103§112 |
Non-Final OA |
24d overdue |
Pending |
Aug 30, 2023 |
| 18547408 |
MAGNETIC SHEAR BIOREACTOR APPARATUS AND METHODS |
The Board Of Regents Of The University Of Texas System |
BOWERS, NATHAN ANDREW |
1799 |
§102§103 |
Non-Final OA |
62d |
Pending |
Aug 22, 2023 |
| 18449675 |
LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF |
The Board Of Regents Of The University Of Texas System |
LAZARO, DOMINIC |
1611 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Aug 14, 2023 |
| 18546141 |
LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
MACFARLANE, STACEY NEE |
1675 |
§103§112 |
Non-Final OA |
26d |
Pending |
Aug 11, 2023 |
| 18264576 |
UNSATURATED DENDRIMERS COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF |
The Board Of Regents Of The University Of Texas System |
SHOMER, ISAAC |
1637 |
§102§103Other |
Non-Final OA |
— |
Pending |
Aug 07, 2023 |
| 18264457 |
LITHIATED METAL ORGANIC FRAMEWORKS WITH A BOUND SOLVENT FOR SECONDARY BATTERY APPLICATIONS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
LI, AIQUN |
1766 |
§102 |
Non-Final OA |
— |
Pending |
Aug 07, 2023 |
| 18275901 |
HUMANIZED GPC3 ANTIBODY AND APPLICATION THEREOF |
Hainan Simcere Zaiming Pharmaceutical Co., Ltd. |
JUEDES, AMY E |
1644 |
§102§112DP |
Non-Final OA |
— |
Pending |
Aug 04, 2023 |
| 18264413 |
INTRAMOLECULAR CYCLIZATION FOR GENERAL SYNTHESIS OF BICYCLIC ALKYL BIOISOSTERE BORONATES |
The Board Of Regents Of The University Of Texas System |
O DELL, DAVID K |
1621 |
§112 |
Non-Final OA |
53d |
Pending |
Aug 04, 2023 |
| 18365712 |
PROCESS OF MANUFACTURE OF ANNEXIN V |
Annexin Pharmaceuticals AB |
IANNUZO, NATALIE NMN |
1653 |
§103§112DP |
Non-Final OA |
— |
Pending |
Aug 04, 2023 |
| 18274845 |
HUMANIZED ANTIBODY AGAINST TNFR2 AND USE THEREOF |
Shandong Simcere Biopharmaceutical Co., Ltd. |
LEE, YIE CHIA |
1642 |
§112 |
Non-Final OA |
— |
Pending |
Jul 28, 2023 |
| 18261983 |
BONE-SPECIFIC DELIVERY OF POLYPEPTIDES |
BAYLOR COLLEGE OF MEDICINE |
DUNN, LINDSAY MICHELLE |
1644 |
§102§103§112 |
Final Rejection |
17d overdue |
Pending |
Jul 18, 2023 |
| 18261732 |
SYNTHETIC URSOLIC ACID DERIVATIVES AND METHODS OF USE THEREOF |
Reata Pharmaceuticals, Inc. |
MURESAN, ANA Z |
1692 |
§102 |
Non-Final OA |
— |
Pending |
Jul 17, 2023 |
| 18260891 |
CROSS-REACTIVE ANTIBODIES RECOGNIZING THE CORONAVIRUS SPIKE S2 DOMAIN |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
MELCHIOR, JAMES RYLAND |
1644 |
§112 |
Non-Final OA |
— |
Pending |
Jul 10, 2023 |
| 18271294 |
DRIED CELL SECRETOME-BASED THERAPEUTIC AGENT FOR OSTEOARTHRITIS TREATMENT |
Seoul National University R&Db Foundation |
RAHMAN, MASUDUR |
1633 |
§103 |
Final Rejection |
27d |
Pending |
Jul 07, 2023 |
| 18271131 |
SPRAY-TYPE HYDROGEL |
Seoul National University R&Db Foundation |
GULLEDGE, BRIAN M |
1699 |
§101§103§112 |
Final Rejection |
3d overdue |
Pending |
Jul 06, 2023 |
| 18270915 |
METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER ON BASIS OF ACTIVITY REGULATION MECHANISM OF DORMANT NEURAL STEM CELL |
Dongguk University Industry-Academic Cooperation Foundation |
GIBBS, TERRA C |
1635 |
§112 |
Final Rejection |
20d |
Pending |
Jul 05, 2023 |
| 18270818 |
NOVEL SKIN-PERMEABLE PEPTIDE, COMPOSITION INCLUDING THE SAME FOR SKIN AND MUCOUS MEMBRANE, AND USE THEREOF |
Cellicon Lab Inc. |
CHANDRAKUMAR, NIZAL S |
1625 |
§103Other |
Non-Final OA |
— |
Pending |
Jul 03, 2023 |
| 18270476 |
ORAL SOLID FORMULATION FOR COLON CLEANSING |
Taejoon Pharmaceutical Co., Ltd. |
ATKINSON, JOSHUA ALEXANDER |
1612 |
§102§103DP |
Non-Final OA |
8d overdue |
Pending |
Jun 29, 2023 |
| 18270028 |
2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF |
Shanghai Kunheng Pharma-Tech Co., Ltd. |
HEITMEIER, KENDALL NICOLE |
1621 |
§102§103Other |
Final Rejection |
26d |
Pending |
Jun 28, 2023 |
| 18256897 |
COMPOSITIONS AND METHODS OF MAKING COCRYSTALS USING DIELECTRIC HEATING WITH DISPERSIVE AND DISTRIBUTIVE MIXING |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
COHEN, MICHAEL P |
1612 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Jun 09, 2023 |
| 18332571 |
ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF |
Research Development Foundation |
BUTTICE, AUDREY L |
1647 |
§103§112 |
Final Rejection |
28d overdue |
Pending |
Jun 09, 2023 |
| 18265780 |
EXHAUST GAS FILTERING APPARATUS AND COATING EQUIPMENT |
Jiangsu Favored Nanotechnology Co., Ltd. |
PENCE, JETHRO M |
1717 |
§102§103 |
Final Rejection |
8d overdue |
Pending |
Jun 07, 2023 |
| 18205628 |
IMMUNOMODULATOR COMPOSITION COMPRISING AZVUDINE |
Henan Genuine Biotech Co., Ltd. |
DAHLIN, HEATHER RAQUEL |
1629 |
§103 |
Final Rejection |
— |
Pending |
Jun 05, 2023 |
| 18254261 |
NOVEL PAR-2 INHIBITORS |
Domain Therapeutics |
PECKHAM, RICHARD GRANT |
1627 |
§102§103 |
Final Rejection |
33d |
Pending |
May 24, 2023 |
| 18320598 |
RNA SEQUENCE ADAPTATION |
CUREVAC SE |
SULLIVAN, STEPHANIE LAUREN |
1635 |
§103 |
Final Rejection |
62d |
Pending |
May 19, 2023 |
| 18253755 |
USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN |
UNIVERSITY OF CAPE TOWN |
DEVI, SARVAMANGALA |
1645 |
§103§112 |
Non-Final OA |
14d |
Pending |
May 19, 2023 |
| 18253687 |
USE OF MATURE MITOCHONDRIAL TRANSCRIPTION FACTOR A (TFAM) FOR DIAGNOSING ORGAN DYSFUNCTIONS |
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH |
VANN-OJUEKAIYE, KENDRA RAYCHELL |
1682 |
§103§112 |
Final Rejection |
29d |
Pending |
May 19, 2023 |
| 18037598 |
SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF |
Youjia (Hangzhou) Biomedical Technology Co., Ltd. |
SHEN, WU CHENG WINSTON |
1682 |
§103§112 |
Non-Final OA |
— |
Pending |
May 18, 2023 |
| 18320187 |
ARTIFICIAL NUCLEIC ACID MOLECULES |
CUREVAC SE |
GRAY, JESSICA |
1682 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 18, 2023 |
| 18037402 |
COMPOSITIONS |
UNIVERSITY OF SOUTHAMPTON |
KATAKAM, SUDHAKAR |
1658 |
§103DP |
Final Rejection |
— |
Pending |
May 17, 2023 |
| 18037282 |
APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS |
Nuclein, LLC |
KRCHA, MATTHEW D |
1796 |
§103§112 |
Final Rejection |
— |
Pending |
May 16, 2023 |
| 18036488 |
SALICYLIC ACID-INDUCIBLE GENE EXPRESSION COMPOSITIONS AND SYSTEMS FOR CELLS |
UNIVERSITY OF HOUSTON SYSTEM |
LEONARD, ARTHUR S |
1631 |
§112 |
Non-Final OA |
27d |
Pending |
May 11, 2023 |
| 18034380 |
Synthesis Method and Application of a Near-infrared Probe GGa-ICG specific binding to PSCA |
Guangzhou Shiyun Biotechnology Co., Ltd. |
SHIAO, YIH-HORNG |
1691 |
§103§112 |
Non-Final OA |
— |
Pending |
Apr 28, 2023 |
| 18033464 |
ANTIBODIES FOR USE IN THE DETECTION AND TREATMENT OF HEART DISEASE |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
MERTZ, PREMA MARIA |
1674 |
§112 |
Final Rejection |
— |
Pending |
Apr 24, 2023 |
| 18250107 |
BRAIN PENETRATING PEPTIDES |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
BORGEEST, CHRISTINA M |
1675 |
§102§103§112 |
Final Rejection |
— |
Pending |
Apr 21, 2023 |
| 18249647 |
ORAL CANNABINOID FORMULATION COMPRISING MEDIUM CHAIN TRIGLYCERIDES AND TOCOPHERYL PHOSPHATES |
Avecho Biotechnology Limited |
KUCHARCZK, JED A |
1623 |
§103DP |
Final Rejection |
2d overdue |
Pending |
Apr 19, 2023 |
| 18028650 |
INJECTABLE CALCIUM PHOSPHATE-BASED BONE GRAFT COMPOSITION HAVING HIGH ELASTICITY AND PREPARATION METHOD THEREOF |
Cg Bio Co., Ltd. |
ZHANG SPIERING, DONGXIU |
1616 |
§103 |
Non-Final OA |
— |
Pending |
Mar 27, 2023 |
| 18026696 |
THERAPEUTIC AGENTS AND USES THEREOF |
The Board Of Regents Of The University Of Texas System |
HOWARD, ZACHARY C |
1674 |
§102§112Other |
Non-Final OA |
— |
Pending |
Mar 16, 2023 |
| 18120191 |
PROGRAMMED CELLS FOR TARGETED ARTICULAR CARTILAGE AND BONE REGENERATION |
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION |
BUTTICE, AUDREY L |
1644 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Mar 10, 2023 |
| 18043976 |
IMPROVED PHARMACEUTICAL FORMULATIONS OF GLP-1 RECEPTOR AGONISTS |
Cyprumed GmbH |
WISTNER, SARAH CLINKSCALES |
1616 |
§103§112DP |
Non-Final OA |
— |
Pending |
Mar 03, 2023 |
| 18043577 |
MANUFACTURING DEVICE FOR A PHARMACEUTICAL PRODUCT |
Tesla Automation GmbH |
SHI, TINGCHEN |
1796 |
§103 |
Final Rejection |
12d |
Pending |
Feb 28, 2023 |
| 18043317 |
MULTIVALENT NUCLEIC ACID BASED CORONAVIRUS VACCINES |
CUREVAC SE |
JADHAO, SAMADHAN JAISING |
1672 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Feb 27, 2023 |
| 18041811 |
NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF |
UNIVERSITY OF CONNECTICUT |
RONEY, CELESTE A |
1612 |
§103 |
Non-Final OA |
16d |
Pending |
Feb 16, 2023 |
| 18041470 |
TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
JONES, DAMERON LEVEST |
1618 |
§103 |
Final Rejection |
21d |
Pending |
Feb 13, 2023 |
| 18041479 |
PHARMACEUTICAL COMPOSITION CONTAINING COCRYSTALS FOR ADDITIVE MANUFACTURING |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
ATKINSON, JOSHUA ALEXANDER |
1612 |
Other |
Final Rejection |
— |
Pending |
Feb 13, 2023 |
| 18041475 |
METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
BAUER, NICOLA MARIA |
1621 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Feb 13, 2023 |
| 18007468 |
NUCLEIC ACID ENCODED ANTIBODY MIXTURES |
CUREVAC SE |
HAM, JIEUN |
1643 |
§103 |
Final Rejection |
93d overdue |
Pending |
Jan 30, 2023 |
| 18018518 |
BROAD-SPECTRUM ANTIVIRAL DRUG FOR ENTEROVIRUS, AND APPLICATION |
Wuhan Institute Of Virology, Chinese Academy Of Sciences |
COFFA, SERGIO |
1658 |
§102§112 |
Non-Final OA |
70d |
Pending |
Jan 27, 2023 |
| 18160926 |
HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES |
Saint Louis University |
HILL, MYRON G |
1671 |
§112 |
Final Rejection |
— |
Pending |
Jan 27, 2023 |
| 18017669 |
USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS |
Stream Biomedical, Inc. |
STEELE, AMBER D |
1658 |
§102§103§112 |
Final Rejection |
28d overdue |
Pending |
Jan 23, 2023 |
| 18016275 |
ANTIBODY DRUG CONJUGATE INTERMEDIATE CONTAINING SN38 AND ITS PREPARATION METHOD |
Mabplex International Co., Ltd. |
SKOKO III, JOHN JOSEPH |
1643 |
§103§112 |
Final Rejection |
83d |
Pending |
Jan 13, 2023 |
| 18004522 |
ADENO-ASSOCIATED VIRUS VECTOR FOR DWARF OPEN READING FRAME |
The Board Of Regents Of The University Of Texas System |
MOLOYE, TITILAYO |
1632 |
§103 |
Final Rejection |
— |
Pending |
Jan 06, 2023 |
| 18149934 |
MECHANICAL OPENING OF LIPID BILAYERS BY MOLECULAR NANOMACHINES |
Durham University |
PERREIRA, MELISSA JEAN |
1618 |
§102§103DP |
Non-Final OA |
— |
Pending |
Jan 04, 2023 |
| 18003412 |
AMPLICON COMPREHENSIVE ENRICHMENT |
William Marsh Rice University |
BERTAGNA, ANGELA MARIE |
1681 |
§101§103§112 |
Final Rejection |
3d overdue |
Pending |
Dec 27, 2022 |
| 18001425 |
MOLECULAR MARKERS AND METHODS FOR SAMPLE ANALYSIS VIA MASS SPECTROMETRY |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
TURPIN, ZACHARY MARK |
1682 |
§103§112 |
Final Rejection |
— |
Pending |
Dec 09, 2022 |
| 18062918 |
METHODS AND COMPOSITIONS FOR NUCLEIC ACID ANALYSIS |
Luminex Corporation |
GRAY, JESSICA |
1682 |
§112DP |
Final Rejection |
— |
Pending |
Dec 07, 2022 |
| 18060134 |
METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS |
Research Development Foundation |
FAN, LYNN Y |
1759 |
§103 |
Non-Final OA |
79d overdue |
Pending |
Nov 30, 2022 |
| 18060183 |
ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS |
Research Development Foundation |
NOBLE, MARCIA STEPHENS |
1632 |
§112 |
Final Rejection |
17d overdue |
Pending |
Nov 30, 2022 |
| 17999960 |
NON-EXTENSIBLE OLIGONUCLEOTIDES IN DNA AMPLIFICATION REACTIONS |
William Marsh Rice University |
CASH, KAILEY ELIZABETH |
1683 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Nov 28, 2022 |
| 18056970 |
METHODS, SYSTEMS AND KITS FOR POLYPEPTIDE PROCESSING AND ANALYSIS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
BOESEN, CHRISTIAN C |
1684 |
§102§112 |
Non-Final OA |
— |
Pending |
Nov 18, 2022 |
| 17998291 |
METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR ANALOGS THEREOF |
Reata Pharmaceuticals Holdings, LLC |
KUCKLA, ANNA GRACE |
1626 |
§103 |
Final Rejection |
— |
Pending |
Nov 09, 2022 |
| 18052476 |
SERINE PROTEASE MOLECULES AND THERAPIES |
Research Development Foundation |
LI, RUIXIANG |
1674 |
§112 |
Non-Final OA |
77d overdue |
Pending |
Nov 03, 2022 |
| 17997696 |
QUANTITATIVE BLOCKER DISPLACEMENT AMPLIFICATION (QBDA) SEQUENCING FOR CALIBRATION-FREE AND MULTIPLEXED VARIANT ALLELE FREQUENCY QUANTITATION |
William Marsh Rice University |
PRIEST, AARON A |
1681 |
§103DP |
Final Rejection |
43d overdue |
Pending |
Nov 01, 2022 |
| 17997453 |
ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
LEE, JAE W |
1656 |
§103 |
Final Rejection |
9d overdue |
Pending |
Oct 28, 2022 |
| 18050687 |
USE OF FATE MODULATORS TO IMPROVE NERVE REGENERATION |
The Board Of Regents Of The University Of Texas System |
MCCORMICK, CATHERINE LYNN |
1638 |
§103§112 |
Final Rejection |
— |
Pending |
Oct 28, 2022 |
| 17996618 |
LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
LIPPERT, JOHN WILLIAM |
1615 |
§103 |
Final Rejection |
14d |
Pending |
Oct 19, 2022 |
| 17932026 |
METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE |
Curevac Manufacturing GmbH |
NGUYEN, QUANG |
1631 |
§103 |
Final Rejection |
— |
Pending |
Sep 14, 2022 |
| 17931440 |
COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF |
Fujifilm Cellular Dynamics, Inc. |
STAVROU, CONSTANTINA E |
1632 |
§103 |
Final Rejection |
— |
Pending |
Sep 12, 2022 |
| 17641048 |
METHOD FOR SEQUENCING RNA OLIGONUCLEOTIDES |
Cemm - Forschungszentrum Für Molekulare Medizin GmbH |
CASH, KAILEY ELIZABETH |
1683 |
§103§112 |
Final Rejection |
— |
Pending |
Sep 08, 2022 |
| 17930505 |
DEEP NEURAL NETWORKS FOR ESTIMATING POLYGENIC RISK SCORES |
The Board Of Regents Of The University Of Oklahoma |
WHALEY, PABLO S |
3619 |
§101§102§112 |
Non-Final OA |
— |
Pending |
Sep 08, 2022 |
| 17905143 |
TREATMENT OF CARM1-OVEREXPRESSING AND/OR ARID1A MUTANT CANCERS WITH IRE-1/XBP-1 INHIBITORS |
The Wistar Institute |
SIMMONS, CHRIS E |
1622 |
§103§112 |
Non-Final OA |
— |
Pending |
Aug 26, 2022 |
| 17905088 |
DIBORIDE MICROPATTERNED SURFACES FOR CELL CULTURE |
UNIVERSITY OF HOUSTON SYSTEM |
TICHY, JENNIFER M.H. |
1653 |
§103§112 |
Non-Final OA |
— |
Pending |
Aug 26, 2022 |
| 17822332 |
TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS |
Yale University |
JOHANNSEN, DIANA B |
1682 |
§103§112DP |
Non-Final OA |
— |
Pending |
Aug 25, 2022 |
| 17821931 |
COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 MUTATIONS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
ENGLISH, CONNOR KENNEDY |
1625 |
§103 |
Non-Final OA |
— |
Pending |
Aug 24, 2022 |
| 17820559 |
METHOD FOR IN VITRO TRANSCRIPTION USING AN IMMOBILIZED RESTRICTION ENZYME |
Curevac AG |
POHNERT, STEVEN C |
1683 |
§103§112 |
Final Rejection |
— |
Pending |
Aug 17, 2022 |
| 17904473 |
CHIMERIC SCAVENGER RECEPTORS TARGETED TO PHOSPHORYLATED TAU (PTAU) AND USES THEREOF |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
HAM, JIEUN |
1643 |
§103§112 |
Non-Final OA |
— |
Pending |
Aug 17, 2022 |
| 17819268 |
DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
HOERNER, PAUL ELLSWORTH |
1611 |
§103§112 |
Non-Final OA |
4d overdue |
Pending |
Aug 11, 2022 |
| 17819234 |
NOVEL ANTIBODIES AND COMBINED USE OF A TREG DEPLETING ANTIBODY AND AN IMMUNOSTIMULATORY ANTIBODY |
Cancer Research Technology Limited |
OUSPENSKI, ILIA I |
1644 |
§102§112DP |
Final Rejection |
77d |
Pending |
Aug 11, 2022 |
| 17929013 |
METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
QIAN, CELINE X |
1637 |
§103 |
Final Rejection |
51d overdue |
Pending |
Aug 10, 2022 |
| 17759817 |
USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
RZECZYCKI, PHILLIP MATTHEW |
1625 |
DP |
Final Rejection |
— |
Pending |
Jul 29, 2022 |
| 17794920 |
COMPOSITIONS AND METHODS TO TREAT NEUROLOGICAL DISEASES |
UNIVERSITY OF SOUTHERN CALIFORNIA |
GIBBS, TERRA C |
1635 |
§103§112 |
Non-Final OA |
72d |
Pending |
Jul 22, 2022 |
| 17814198 |
T CELLS EXPRESSING MEMBRANE-ANCHORED IL-12 FOR THE TREATMENT OF CANCER |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
LIU, SUE XU |
1616 |
§102§103DP |
Non-Final OA |
— |
Pending |
Jul 21, 2022 |
| 17746569 |
ANTI-CD300C MONOCLONAL ANTIBODY AND BIOMARKER THEREOF FOR PREVENTING OR TREATING CANCER |
Centricsbio, Inc. |
BERHANE, SELAM |
1675 |
§112 |
Non-Final OA |
— |
Pending |
May 17, 2022 |
| 17773682 |
TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR THE TREATMENT OF CANCER |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
ZARA, JANE J |
1637 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 02, 2022 |
| 17770601 |
BIOLOGICAL SAMPLE COLLECTION PAD |
ZYMO RESEARCH CORPORATION |
MCCORMACK, ERIN KATHLEEN |
3791 |
§103§112 |
Non-Final OA |
— |
Pending |
Apr 20, 2022 |
| 17698906 |
COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS TO TREAT LUNG DISEASE |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
KWON, JOHN SEUNGJAI |
1615 |
§103 |
Final Rejection |
28d overdue |
Pending |
Mar 18, 2022 |
| 17693062 |
METHODS TO PREPARE DRY POWDERS USING SUSPENSION BASED THIN FILM FREEZING |
Tff Pharmaceuticals, Inc. |
GOTFREDSON, GAREN |
1619 |
§103§112 |
Non-Final OA |
60d overdue |
Pending |
Mar 11, 2022 |
| 17679698 |
COMPOSITIONS AND METHODS FOR TREATING CANINE PARVOVIRUS INFECTION |
Moxxitech, LLC |
KETCHAM, KAREN A |
1614 |
§103 |
Non-Final OA |
— |
Pending |
Feb 24, 2022 |
| 17589879 |
METHOD FOR PRODUCING RNA |
Curevac Real Estate GmbH |
YU, TIAN NMN |
1681 |
§103 |
Non-Final OA |
— |
Pending |
Jan 31, 2022 |
| 17586258 |
MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF |
The Board Of Regents Of The University Of Texas System |
REYNOLDS, FRED H |
1658 |
§112 |
Final Rejection |
— |
Pending |
Jan 27, 2022 |
| 17576583 |
ARTIFICIAL NUCLEIC ACID MOLECULES |
Curevac AG |
LEITH, NANCY J |
1636 |
§101§103§112Other |
Non-Final OA |
30d |
Pending |
Jan 14, 2022 |
| 17576597 |
DENDRITIC CELL IMMUNOTHERAPY |
BAYLOR COLLEGE OF MEDICINE |
JUEDES, AMY E |
1644 |
§103§112DP |
Non-Final OA |
132d overdue |
Pending |
Jan 14, 2022 |
| 17620605 |
METHODS FOR DUPLEX SEQUENCING OF CELL-FREE DNA AND APPLICATIONS THEREOF |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
PARISI, JESSICA DANIELLE |
1684 |
§103 |
Final Rejection |
— |
Pending |
Dec 17, 2021 |
| 17554861 |
METHODS FOR NUCLEIC ACID CAPTURE |
ZYMO RESEARCH CORPORATION |
LEONARD, ARTHUR S |
1631 |
§103 |
Final Rejection |
— |
Pending |
Dec 17, 2021 |
| 17620047 |
ROTAVIRUS MRNA VACCINE |
Curevac AG |
GRABER, JAMES J |
1631 |
§103DP |
Final Rejection |
8d overdue |
Pending |
Dec 16, 2021 |
| 17619096 |
METHODS FOR THE PRODUCTION OF MULTIPLE LINEAGES FROM INDUCED PLURIPOTENT STEM CELLS USING CHARGED SURFACES |
Fujifilm Holdings America Corporation |
BEHARRY, ZANNA MARIA |
1632 |
§103§112 |
Final Rejection |
8d overdue |
Pending |
Dec 14, 2021 |
| 17548467 |
SYSTEMS AND METHODS FOR LASER-INDUCED CALCIUM FRACTURES |
Research Development Foundation |
ANJARIA, SHREYA PARAG |
3796 |
§103 |
Non-Final OA |
134d overdue |
Pending |
Dec 10, 2021 |
| 17611315 |
METHODS AND APPARATUS FOR HIGH-SPEED AND HIGH-ASPECT RATIO LASER SUBTRACTIVE MATERIAL PROCESSING |
Research Development Foundation |
FEDORKY, MEGAN TAYLOR |
3796 |
§103§112 |
Non-Final OA |
— |
Pending |
Nov 15, 2021 |
| 17607837 |
MICRO-RNA SITE BLOCKING OLIGONUCLEOTIDES FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY AND NEURODEVELOPMENTAL DISORDERS |
The Trustees of the University of Pennsylvania |
SULLIVAN, STEPHANIE LAUREN |
1635 |
§103 |
Non-Final OA |
6d |
Pending |
Oct 29, 2021 |
| 17604560 |
COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
ROBINSON, MIKHAIL O'DONNEL |
1627 |
§103§112 |
Final Rejection |
12d |
Pending |
Oct 18, 2021 |
| 17600600 |
COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
DONOGHUE, BRITTNEY ERIN |
1675 |
§103§112 |
Non-Final OA |
19d overdue |
Pending |
Sep 30, 2021 |
| 17441869 |
SURFACE-MODIFIED DOPED TITANIUM DIOXIDE NANOPARTICLES AND USES |
The Board Of Regents Of The University Of Oklahoma |
PROSSER, ALISSA J |
1619 |
§103§112Other |
Final Rejection |
— |
Pending |
Sep 22, 2021 |
| 17429182 |
CODING RNA ADMINISTERED INTO THE SUPRACHOROIDAL SPACE IN THE TREATMENT OF OPHTHALMIC DISEASES |
Curevac AG |
FAY, ZOHREH ALEMZADEH |
1617 |
§103§112 |
Final Rejection |
73d overdue |
Pending |
Aug 06, 2021 |
| 17378954 |
COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC) |
Curevac AG |
WILSON, MICHAEL C |
1638 |
§103 |
Non-Final OA |
81d overdue |
Pending |
Jul 19, 2021 |
| 17416227 |
COMBINATION THERAPY FOR THE TREATMENT OF CANCER |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
DENT, ALANA HARRIS |
1643 |
§102§103 |
Final Rejection |
— |
Pending |
Jun 18, 2021 |
| 17235771 |
BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
NGUYEN, JOHN P |
1619 |
§103 |
Final Rejection |
17d overdue |
Pending |
Apr 20, 2021 |
| 17199120 |
TARGETS FOR RNA THERAPEUTICS |
CUREVAC SE |
MCKILLOP, JOHN CHARLES |
1637 |
§103 |
Non-Final OA |
— |
Pending |
Mar 11, 2021 |
| 17193511 |
TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
GODDARD, LAURA B |
1642 |
DP |
Final Rejection |
— |
Pending |
Mar 05, 2021 |
| 17272005 |
SCALABLE TAGGING OF ENDOGENOUS GENES BY HOMOLOGY-INDEPENDENT INTRON TARGETING |
The Children's Hospital of Philadelphia |
REGA, KYLE THOMAS |
1636 |
§103 |
Final Rejection |
16d |
Pending |
Feb 26, 2021 |
| 17054312 |
PROXIMITY INDUCED SITE-SPECIFIC ANTIBODY CONJUGATION |
William Marsh Rice University |
VAN DRUFF, SYDNEY |
1643 |
§103 |
Final Rejection |
12d |
Pending |
Nov 10, 2020 |
| 17047967 |
MITOCHONDRIAL RNA IMPORT FOR TREATING MITOCHONDRIAL DISEASE |
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
VYAS, KEYUR ANILKUMAR |
1637 |
§101§103 |
Final Rejection |
87d overdue |
Pending |
Oct 15, 2020 |
| 17045236 |
NOVEL YELLOW FEVER NUCLEIC ACID MOLECULES FOR VACCINATION |
CUREVAC SE |
VYAS, KEYUR ANILKUMAR |
1637 |
§103 |
Final Rejection |
72d overdue |
Pending |
Oct 05, 2020 |
| 16975058 |
FORMULATIONS CONTAINING MUCIN-AFFECTING PROTEASES |
Mucpharm Pty Ltd. |
FERNANDEZ, SUSAN EMILY |
1651 |
§112 |
Non-Final OA |
— |
Pending |
Aug 21, 2020 |
| 16933773 |
NUCLEIC ACID PURIFICATION |
ZYMO RESEARCH CORPORATION |
NGUYEN, QUANG |
1631 |
§103 |
Final Rejection |
100d overdue |
Pending |
Jul 20, 2020 |
| 16860004 |
MULTIVASCULAR NETWORKS AND FUNCTIONAL INTRAVASCULAR TOPOLOGIES WITHIN BIOCOMPATIBLE HYDROGELS |
William Marsh Rice University |
PELLEGRINO, BRIAN E |
3799 |
§103§112 |
Final Rejection |
— |
Pending |
Apr 27, 2020 |
| 16757297 |
METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA |
ZYMO RESEARCH CORPORATION |
GREENE, CAROLYN LEE |
1681 |
§103 |
Non-Final OA |
9d |
Pending |
Apr 17, 2020 |
| 16834504 |
COMPACT FLUID WARMER |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
EKRAMI, YASAMIN |
3794 |
§103 |
Final Rejection |
19d overdue |
Pending |
Mar 30, 2020 |
| 16783376 |
METHODS FOR CONDUCTING ASSAYS |
Meso Scale Technologies, Llc. |
TRAN, CHAU NGUYEN BICH |
1677 |
§103 |
Final Rejection |
— |
Pending |
Feb 06, 2020 |
| 16782772 |
METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS |
Fujifilm Cellular Dynamics, Inc. |
NOBLE, MARCIA STEPHENS |
1632 |
§112 |
Non-Final OA |
— |
Pending |
Feb 05, 2020 |
| 16098145 |
IMPROVED DRUG FORMULATIONS |
AustinPx, LLC |
CRAIGO, WILLIAM A |
1615 |
§103 |
Final Rejection |
98d overdue |
Pending |
Nov 01, 2018 |
| 15750745 |
METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE |
Curevac Manufacturing GmbH |
NGUYEN, QUANG |
1631 |
§103 |
Final Rejection |
— |
Pending |
Feb 06, 2018 |
